| tyrosine phosphorylation | <enzyme> Kinases that phosphorylate protein tyrosine residues. These kinases play major roles in mitogenic signalling and can be divided into two subfamilies: receptor tyrosine kinases, that have an extracellular ligand binding domain, a single transmembrane domain and an intracellular tyrosine kinase domain and nonreceptor tyrosine kinases, which are soluble, cytoplasmic kinases. (18 Nov 1997) |
|---|---|
| tyrosine-repressible transaminase | <enzyme> From E coli; catalyses the amination of 2-ketoisocaproate to leucine; encoded by tyrb; a functional leuabcd operon is required for leucine synthesis by this enzyme Registry number: EC 2.6.1.- Synonym: transaminase d, tyrosine-2-ketoisocaproate aminotransferase (26 Jun 1999) |
| tyrosine transaminase | <enzyme> An enzyme that catalyses the conversion of l-tyrosine and 2-oxoglutarate to 4-hydroxyphenylpyruvate and l-glutamate. It is a pyridoxal-phosphate protein. L-phenylalanine can act instead of l-tyrosine. The mitochondrial enzyme may be identical with aspartate transaminase (ec 2.6.1.1.). Chemical name: L-Tyrosine:2-oxoglutarate aminotransferase Registry number: EC 2.6.1.5 (12 Dec 1998) |
| tyrosine-trna ligase | <enzyme> An enzyme that activates tyrosine with its specific transfer RNA. Chemical name: L-Tyrosine:tRNA-(Tyr) ligase (AMP-forming) Registry number: EC 6.1.1.1 (12 Dec 1998) |
| L-tyrosine ammonia-lyase | <enzyme> Catalyses the conversion of tyrosine to trans-p-coumaric acid and ammonia Registry number: EC 4.3.1.- Synonym: tyrosine ammonia-lyase (26 Jun 1999) |
| lymphocyte specific protein tyrosine kinase p56(lck) | <enzyme> This enzyme is a lymphoid specific src family tyrosine kinase that is critical for T-cell development and activation. Lck is associated with the cytoplasmic domains of CD4, CD8 and the beta-chain of the il-2 receptor, and is thought to be involved in the earliest steps of tcr-mediated T-cell activation. Registry number: EC 2.7.11.- (12 Dec 1998) |
| administration, oral | The giving of drugs, chemicals, or other substances by mouth. (12 Dec 1998) |
| cancer, oral | Cancer of the mouth area. A sore in the mouth that does not heal can be a warning sign of oral cancer. A biopsy is the only to know whether as abnormal area in the oral cavity is cancer. Oral cancer is caused by tobacco (smoking and chewing) and alcohol use. Surgery to remove the tumour in the mouth is the usual treatment for patients with oral cancer. (12 Dec 1998) |
| candidiasis, oral | Infection of the mucous membranes of the mouth by a fungus of the genus candida. (12 Dec 1998) |
| canine oral papilloma | Warts affecting mucous membranes of young dogs; caused by a papillomavirus. (05 Mar 2000) |
| magnesia and alumina oral suspension | A mixture of magnesium hydroxide and variable amounts of aluminum oxide; used as an antacid. (05 Mar 2000) |
| pathology, oral | A dental specialty concerned with pathology of the oral cavity. (12 Dec 1998) |
| pharyngo-oral | Relating to the pharynx and the mouth; oropharyngeal. Origin: pharyngo-+ L. Os (or-), mouth (05 Mar 2000) |
| combination oral contraceptive | A mixture of a steroid having progestational activity and an oestrogen. (05 Mar 2000) |
| contraceptives, oral | Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally oestrogen or progesterone or both. (12 Dec 1998) |